Vendor Intelligence Report: Crush Research

Published 3 Jul 2026. 27-page investigative report on who is behind Crush Research: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Across 4 Finnrick lab tests, Crush Research records a 100% pass rate, but the evidence is narrow: all coverage is Retatrutide, now sold as Triple Agonist. The report weighs that favorable product…